Save the date for BLOODPAC’s virtual annual New Frontiers seminar taking place on November 5, 2025, from 1:00–3:00 PM EST. 

This year’s topic "New Frontiers in Therapy Selection: Beyond DNA Mutations" will focus on the integration of multimodal data to inform and support therapy selection. The program will highlight emerging tools, such as RNA and epigenetic signatures, digital pathology, and more, and examine how they can be combined with liquid biopsy to capture real-time, multi-omic tumor dynamics. We’ll also discuss the challenges and opportunities of bringing these next-generation approaches into clinical practice to expand access and advance personalized cancer care.

Register for the event here.